FR2437830A1 - Nouvelle forme galenique de la trinitroglycerine - Google Patents

Nouvelle forme galenique de la trinitroglycerine

Info

Publication number
FR2437830A1
FR2437830A1 FR7828339A FR7828339A FR2437830A1 FR 2437830 A1 FR2437830 A1 FR 2437830A1 FR 7828339 A FR7828339 A FR 7828339A FR 7828339 A FR7828339 A FR 7828339A FR 2437830 A1 FR2437830 A1 FR 2437830A1
Authority
FR
France
Prior art keywords
tri
microporous polymer
trinitroglycerin
nitroglycerin
angina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7828339A
Other languages
English (en)
Other versions
FR2437830B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Priority to FR7828339A priority Critical patent/FR2437830A1/fr
Publication of FR2437830A1 publication Critical patent/FR2437830A1/fr
Application granted granted Critical
Publication of FR2437830B1 publication Critical patent/FR2437830B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'INVENTION CONCERNE UNE NOUVELLE FORME GALENIQUE DE LA TRINITROGLYCERINE. ELLE EST REMARQUABLE EN CE QU'ELLE EST CONSTITUEE PAR UN SUPPORT EN FILM SOUPLE RECOUVERT PAR UNE PELLICULE D'UN POLYMERE MICROPOREUX DE STRUCTURE LACUNAIRE DANS LEQUEL LESDITES LACUNES SONT OCCUPEES PAR LA TRINITROGLYCERINE, LEDIT SUPPORT ETANT DESTINE A ETRE APPLIQUE SUR LA PEAU. APPLICATION A L'ATTENTION DE MEDICAMENTS POUR LE TRAITEMENT DE L'ANGOR.
FR7828339A 1978-10-04 1978-10-04 Nouvelle forme galenique de la trinitroglycerine Granted FR2437830A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7828339A FR2437830A1 (fr) 1978-10-04 1978-10-04 Nouvelle forme galenique de la trinitroglycerine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7828339A FR2437830A1 (fr) 1978-10-04 1978-10-04 Nouvelle forme galenique de la trinitroglycerine

Publications (2)

Publication Number Publication Date
FR2437830A1 true FR2437830A1 (fr) 1980-04-30
FR2437830B1 FR2437830B1 (fr) 1981-12-11

Family

ID=9213323

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7828339A Granted FR2437830A1 (fr) 1978-10-04 1978-10-04 Nouvelle forme galenique de la trinitroglycerine

Country Status (1)

Country Link
FR (1) FR2437830A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0013606A2 (fr) * 1979-01-11 1980-07-23 Key Pharmaceuticals, Inc. Dispositif pour la libération d'un composé actif et procédé pour sa préparation
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
WO1982000005A1 (fr) * 1980-06-26 1982-01-07 Key Pharma Matrice polymere de diffusion contenant un vaso-dilatateur
JPS5714529A (en) * 1980-07-02 1982-01-25 Nippon Kayaku Co Ltd Stabilized nitroglycerin composition
FR2488134A1 (fr) * 1980-08-11 1982-02-12 Searle & Co Tampon de nitroglycerine transdermique
FR2515045A1 (fr) * 1981-10-23 1983-04-29 Cird Matrice de diffusion polymerique a base d'anthraline ou de l'un de ses derives et son application dans le traitement des maladies de la peau
US4460562A (en) * 1982-01-06 1984-07-17 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing propranolol

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2003304A1 (fr) * 1968-03-06 1969-11-07 Ceskoslovenska Akademie Ved
DE1937073A1 (de) * 1969-07-17 1971-02-04 Schering Ag AEusserlich applizierbares Mittel gegen Psoriasis vulgaris und maligne Neubildungen der Haut
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3699963A (en) * 1969-10-31 1972-10-24 Alza Corp Therapeutic adhesive patch
CH543281A (de) * 1970-11-05 1973-12-14 Alza Corp Einrichtung für die Verabreichung von Empfängnis-verhütungsmitteln
US4076798A (en) * 1975-05-29 1978-02-28 American Cyanamid Company High molecular weight polyester resin, the method of making the same and the use thereof as a pharmaceutical composition

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2003304A1 (fr) * 1968-03-06 1969-11-07 Ceskoslovenska Akademie Ved
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
DE1937073A1 (de) * 1969-07-17 1971-02-04 Schering Ag AEusserlich applizierbares Mittel gegen Psoriasis vulgaris und maligne Neubildungen der Haut
US3699963A (en) * 1969-10-31 1972-10-24 Alza Corp Therapeutic adhesive patch
CH543281A (de) * 1970-11-05 1973-12-14 Alza Corp Einrichtung für die Verabreichung von Empfängnis-verhütungsmitteln
US4076798A (en) * 1975-05-29 1978-02-28 American Cyanamid Company High molecular weight polyester resin, the method of making the same and the use thereof as a pharmaceutical composition

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0013606A2 (fr) * 1979-01-11 1980-07-23 Key Pharmaceuticals, Inc. Dispositif pour la libération d'un composé actif et procédé pour sa préparation
EP0013606A3 (en) * 1979-01-11 1981-01-07 Key Pharmaceuticals, Inc. Polymeric diffusion matrix, method of its preparation and drug delivery device comprising said matrix
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4292301A (en) * 1979-08-14 1981-09-29 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing ephedrine
US4292303A (en) * 1979-08-14 1981-09-29 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing clonidine
US4292302A (en) * 1979-08-14 1981-09-29 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing terbutaline
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4294820A (en) * 1979-08-14 1981-10-13 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing phenylephrine
US4492685A (en) * 1979-08-14 1985-01-08 Key Pharmaceuticals, Inc. Protective skin matrix
WO1982000005A1 (fr) * 1980-06-26 1982-01-07 Key Pharma Matrice polymere de diffusion contenant un vaso-dilatateur
JPS5714529A (en) * 1980-07-02 1982-01-25 Nippon Kayaku Co Ltd Stabilized nitroglycerin composition
JPH027927B2 (fr) * 1980-07-02 1990-02-21 Nippon Kayaku Kk
FR2488134A1 (fr) * 1980-08-11 1982-02-12 Searle & Co Tampon de nitroglycerine transdermique
FR2515045A1 (fr) * 1981-10-23 1983-04-29 Cird Matrice de diffusion polymerique a base d'anthraline ou de l'un de ses derives et son application dans le traitement des maladies de la peau
US4460562A (en) * 1982-01-06 1984-07-17 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing propranolol

Also Published As

Publication number Publication date
FR2437830B1 (fr) 1981-12-11

Similar Documents

Publication Publication Date Title
ES388980A1 (es) Procedimiento para la elaboracion de una lamina de unguentopara tratamientos dermatologicos.
ES539414A0 (es) Mejoras en la fabricacion de preparados del tipo de absorcion percutanea y procedimiento correspondiente
ATE333898T1 (de) Glycerinmonolaurat und laurylacetat enthaltende mittel zur hautpenetrationsbeschleunigung
EP0177893A3 (fr) Formes de dosage à la libération retardée à base de gels de cellulose-éthers hautement plastifiés
NO178526C (no) Fremgangsmåte for fremstilling av en ny, fast og porös enhetsform omfattende mikropartikler og/eller nanopartikler
KR900700128A (ko) 외상 치료법
IL48690A (en) Fluoroacylated ethyl cellulose derivative and blood oxygenation device comprising layer thereof
GB2024012A (en) Oxygen-generating surgical dressing
ATE68089T1 (de) Eine klebende seite aufweisender absorbierender verband und verfahren zu seiner herstellung.
PT87125A (pt) Process for preparing transdermal therapeutic systems for combined administration of oestrogens and gestagens
NO895172L (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff.
LU88849I2 (fr) Climara
FR2437830A1 (fr) Nouvelle forme galenique de la trinitroglycerine
NO884530L (no) Plaster med aktive stoffer for styrt avgivelse av aktive stoffer til huden, anvendelse saavel som fremgangsmaate for styrt avgivelse av aktive stoffer til huden.
DK4481A (da) Hydroxyalkylstivelse som laegemiddelbaerer
ES8704740A1 (es) Procedimiento para preparar un producto farmaceutico para la entrega controlada de sustancias activas a la piel,preferentemente en forma de un emplasto
AR215499A1 (es) Procedimiento para preparar colageno poroso,de aplicacion en el tratamiento y cuidado de la piel
GB1377022A (en) Structure having a microcrystalline collagen layer and method of preparing the same
EP0267293A4 (fr) Agent de pretraitement pour administration percutanee.
JPS5583710A (en) Spongy enzyme preparation
NL185454C (nl) Esterderivaat van een anti-inflammatoir werkzaam carbonzuur, werkwijze voor het bereiden daarvan en farmaceutisch preparaat met anti-inflammatoire werking.
ATE64539T1 (de) Dermale und transdermale therapeutische systeme mit musterfoermig aufgetragener klebschicht, sowie verfahren zur dessen herstellung.
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
NL180415C (nl) Esters van 2,2-dimethylcyclopropaancarbonzuur, alsmede insecticidepreparaat.
JPS5917860Y2 (ja) 生理活性物質供給体

Legal Events

Date Code Title Description
ST Notification of lapse
RC Opposition against decision of lapse
DA Annulment of decision of lapse
GC Lien (pledge) constituted